World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
98
Citations
55230
World Ranking
8750
National Ranking
4511

Overview

Matthew B. Stern is affiliated with the University of Pennsylvania in the United States and has contributed to the field of medicine, with a primary focus on neurology and related subfields.

Their research encompasses several topics, including:

  • Parkinson's Disease Mechanisms and Treatments
  • Neurological disorders and treatments
  • Genetic Neurodegenerative Diseases
  • Botulinum Toxin and Related Neurological Disorders
  • Attention Deficit Hyperactivity Disorder

Stern's recent publications highlight contributions mainly in the area of movement disorders. These include:

  • "In Memoriam Kapil Sethi, MD (1953-2024)" (2024), published in Movement Disorders
  • "In Memoriam Kapil Sethi, M.D. (1953-2024)" (2024), published in Movement Disorders Clinical Practice

The primary venues for Stern's research publications are:

  • Movement Disorders
  • Movement Disorders Clinical Practice

The field of study for Stern is primarily medicine, with four publications classified under neurology, one under cellular and molecular neuroscience, and one related to psychiatry and mental health.

Frequent collaborators in their work include:

  • Anthony E. Lang
  • Victor S.C. Fung
  • Kailash P. Bhatia
  • David J. Burn
  • Christopher G. Goetz

Best Publications

  • Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.

    Christopher G. Goetz;Barbara C. Tilley;Stephanie R. Shaftman;Glenn T. Stebbins

  • MDS clinical diagnostic criteria for Parkinson's disease

    Ronald B. Postuma;Daniela Berg;Matthew Stern;Werner Poewe

  • The Parkinson Progression Marker Initiative (PPMI)

    Kenneth Marek;Danna Jennings;Shirley Lasch;Andrew Siderowf

  • Bilateral Deep Brain Stimulation vs Best Medical Therapy for Patients With Advanced Parkinson Disease: A Randomized Controlled Trial

    Frances M. Weaver;Frances M. Weaver;Kenneth Follett;Matthew Stern;Matthew Stern;Kwan Hur

  • Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan.

    Christopher G. Goetz;Stanley Fahn;Pablo Martinez-Martin;Werner Poewe

  • Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease.

    Kenneth A. Follett;Kenneth A. Follett;Frances M. Weaver;Matthew Stern;Kwan Hur

  • Variable expression of Parkinson's disease A base‐line analysis of the DAT ATOP cohort

    Joseph Jankovic;Michael P McDermott;Jonathan T Carter;Susan A Gauthier

  • Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease

    S. Hoops;S. Nazem;A. D. Siderowf;J. E. Duda

  • Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline.

    Clifford W. Shults;David Oakes;Karl Kieburtz;M. Flint Beal

  • MDS research criteria for prodromal Parkinson's disease

    Daniela Berg;Ronald B. Postuma;Charles H. Adler;Bastiaan R. Bloem

  • The scientific and clinical basis for the treatment of Parkinson disease (2009)

    C. Warren Olanow;Matthew B. Stern;Kapil Sethi

  • Association of dopamine agonist use with impulse control disorders in Parkinson disease.

    Daniel Weintraub;Andrew D. Siderowf;Marc N. Potenza;Joseph Goveas

  • Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial.

    William J Marks;Raymond T Bartus;Joao Siffert;Charles S Davis

  • Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson’s disease

    H.I. Hurtig;J.Q. Trojanowski;J. Galvin;D. Ewbank

  • A controlled trial of rasagiline in early Parkinson disease: The tempo study

    Andrew Siderowf;Matthew Stern;Ira Shoulson;Karl Kieburtz

  • Mitochondrial Polymorphisms Significantly Reduce the Risk of Parkinson Disease

    Joelle M. van der Walt;Kristin K. Nicodemus;Eden R. Martin;William K. Scott

  • Validation of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease

    Daniel Weintraub;Staci Hoops;Judy A. Shea;Judy A. Shea;Kelly E. Lyons

  • Randomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomes.

    Frances M. Weaver;Frances M. Weaver;Kenneth A. Follett;Matthew B. Stern;Matthew B. Stern;Ping Luo

  • Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease

    Daniela Berg;Ronald B. Postuma;Bastiaan Bloem;Piu Chan

  • Effect of Psychiatric and Other Nonmotor Symptoms on Disability in Parkinson's Disease

    Daniel Weintraub;Paul J. Moberg;John E. Duda;Ira R. Katz

Frequent Co-Authors

Andrew Siderowf
Andrew Siderowf University of Pennsylvania
John E. Duda
John E. Duda University of Pennsylvania
Howard I. Hurtig
Howard I. Hurtig University of Pennsylvania
Daniel Weintraub
Daniel Weintraub University of Pennsylvania
Gordon H. Baltuch
Gordon H. Baltuch University of Pennsylvania
Joseph Jankovic
Joseph Jankovic Baylor College of Medicine
Christopher G. Goetz
Christopher G. Goetz Rush University Medical Center
Kenneth Marek
Kenneth Marek Institute for Neurodegenerative Disorders
Anthony E. Lang
Anthony E. Lang University of Toronto
Murray Grossman
Murray Grossman University of Pennsylvania

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in a medical career but prefer a more flexible route, there are a range of online degrees and alternative pathways to consider. Many students choose to begin their journey with rn to bsn online programs, which allow registered nurses to earn their Bachelor of Science in Nursing remotely—often at affordable tuition rates.

For individuals with a non-nursing bachelor’s degree, online direct entry msn programs for non-nursing majors provide a fast-track into advanced nursing roles. These programs can help career changers enter the healthcare field more quickly.

Some aspiring nurses face challenges with admissions. Exploring nursing programs with high acceptance rates may increase your chances of getting started, offering options with flexible entry requirements.

Not all medical careers require clinical work. For those drawn to healthcare administration or data, you could pursue training through accredited medical billing and coding schools online with financial aid.

These varied pathways let students shape their education around personal goals and lifestyle needs, while opening doors to rewarding roles in the healthcare industry.

Best Scientists Citing Matthew B. Stern

Trending Scientists

Recently Published Articles